约翰斯·霍普金斯大学的团队在这项新研究中认为,之前这种疗法给了我们很大帮助,现在在对抗新冠肺炎的治疗中也能成为重要而且实用的疗法。他们还补充说抗体疗法也可以紧急提供。
"Deployment of this option requires no research or development," says immunologist Arturo Casadevall.
免疫学家Arturo Casadevall说:“采用这种方法不需要进行研究或开发。”
"It could be deployed within a couple of weeks since it relies on standard blood-banking practices."
“几周内就能实现,因为它依赖的是标准血库操作规程。”
For the treatment to work, recovered coronavirus patients would need to donate their blood after recovering from COVID–19 and while still convalescing from the disease. During this phase, the blood serum would contain high amounts of natural antibodies produced to combat the SARS-CoV–2 virus.
为了起到治疗作用,康复的新冠肺炎患者需要在病情好转之后的康复期内献血。在这一时期,血清中产生的对抗新冠病毒的自然抗体的含量很高。
【美国专家考虑用新冠康复者的血液做短期疫苗】相关文章:
★ 肥皂会变脏吗?
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15